| Omair Mohammad Javed, MD | |
|
401 Haddon Ave, Room 369, Camden, NJ 08103 | |
| (856) 757-7848 | |
| Not Available |
| Full Name | Omair Mohammad Javed |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 12 Years |
| Location | 401 Haddon Ave, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043578974 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA09714200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital Fontana/ontario | Fontana, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
For four students from British Columbia, their stories of perseverance in pursuing their hopes and dreams despite their illnesses is why they have been awarded $5,000 CAN each as the 2010 recipients of the UCBeyond Scholarship.
Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation. The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.
› Verified 7 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979834 PECOS PAC ID: 6002729175 Enrollment ID: O20040126000823 |
News Archive
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
For four students from British Columbia, their stories of perseverance in pursuing their hopes and dreams despite their illnesses is why they have been awarded $5,000 CAN each as the 2010 recipients of the UCBeyond Scholarship.
Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation. The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Omair Mohammad Javed, MD 401 Haddon Ave, Room 369, Camden, NJ 08103-1505 Ph: (856) 757-7848 | Omair Mohammad Javed, MD 401 Haddon Ave, Room 369, Camden, NJ 08103 Ph: (856) 757-7848 |
News Archive
Legislation that could push more than 100,000 low-income senior citizens in Massachusetts into managed care health plans spurred intense lobbying yesterday, as consumer advocates argued the measure would strip patients of their freedom to stay in traditional Medicare, while proponents said it could save the state significant money.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
For four students from British Columbia, their stories of perseverance in pursuing their hopes and dreams despite their illnesses is why they have been awarded $5,000 CAN each as the 2010 recipients of the UCBeyond Scholarship.
Goodwin Biotechnology Inc., a full service Contract Biomanufacturing Company and Macrocyclics, Inc., a manufacturer of customized chelating agents, jointly announced today their collaborative agreement on Chelation and Bioconjugation. The collaboration will strengthen joint customer projects in Nuclear Medicine involving Chelation, Bioconjugation and GMP manufacturing.
› Verified 7 days ago
Howard Isadore Kesselheim, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 855-632-2667 | |
Richard Arthur Hellander, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Federal St, Camden, NJ 08103 Phone: 856-583-2400 | |
Sivakoti Nagireddy Guda, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave Fl 6, Camden, NJ 08103 Phone: 856-757-3500 | |
Steven Mudroch Ii, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz Rm 513, Camden, NJ 08103 Phone: 856-963-3715 Fax: 856-635-1052 | |
Dr. Bradley Foster Bender, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-3150 | |
Dr. Amanda A Valvano, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Niku Thomas, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2488 |